JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Maslah N,Kaci N,Roux B,Alexe G,Marie R,Pasquer H,Verger E,De Oliveira R,Culeux C,Mlayah B,Gauthier N,Gonzales F,Zhao L,Ganesan S,Gou P,Ling F,Soret-Dulphy J,Parquet N,Vainchenker W,Raffoux E,Padua R,Giraudier S,Marty C,Plo I,Lobry C,Stegmaier K,Puissant A,Kiladjian J,Cassinat B,Benajiba L
Source :
Springer Science and Business Media LLC
2025 Jul 8
Pmid / DOI:
10.1038/s41467-025-60884-1